The transcription factor p63 is a member of the p53 transcription factor family, which has been expressed in CRC CSCs, while p63 mutation is associated with poor clinical prognosis among CRC patients (Pignon et al., 2013; Bahnassy et al., 2014). The gene discussed is TP53; the disease is colorectal carcinoma.